Companies/Windtree Therapeutics, Inc.

Company profile

Windtree Therapeutics, Inc.

OTC: WINT · Healthcare · Biotechnology

PublicHQ Warrington, PACIK 0000946486Reports USD

#990 of 1,394 Healthcare companies by revenue70th-percentile growth

EA Score

——

FH —DQ 28GM —SS 51

v0.1 · 25/100 weight · pillars only

↑ listing tenure, return on assets · ↓ operating margin, 3-yr revenue growth

Methodology →

Revenue TTM

$90.0k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.8M

Employees

Market cap

$674.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$198.0k$198.0k2020

Net income-$1.8M-$1.8M2024

Operating income-$26.1M-$26.1M2024

Total assets$27.9M$27.9M2024

Liabilities$14.7M$14.7M2024

Equity$10.0M$10.0M2024

Revenue trend

FY2018 – FY2020 · USD

$1.5M

FY18

$204.0k

FY18

$1.1M

FY18

$229.0k

FY18

$1.8M

FY18

$40.0k

FY19

$158.0k

FY19

$198.0k

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Windtree Therapeutics, Inc. booked $198.0k in FY2020 revenue, growing 25% year over year — faster than most Healthcare companies we track, at a -902.5% net margin.

Peers · Healthcare

Pond Technologies Holdings Inc.21D MYND Life Sciences Inc.——Clearside Biomedical, Inc.——Medical Care Technologies Inc.——

Key facts

CEOJed A. Latkin

SectorHealthcare

IndustryBiotechnology

HeadquartersWarrington, PA

ExchangeOTC: WINT

Employees14

IPO date1995-08-07

Latest filings

8-K2026-01-07 8-K2025-12-02 10-Q2025-11-19 8-K2025-10-16 8-K2025-10-06 8-K2025-09-08 8-K2025-09-02 8-K2025-08-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.